
    
      A Phase â…¡, prospective, 24 weeks, double-blind, placebo-controlled, randomized, multi-center
      clinical trial for the evaluation of the efficacy and safety of DW1029M on microalbuminuria
      in Patients With Diabetic Nephropathy
    
  